ADVERTISING

Amendments

Political campaigns: ethics reform and contribution limits (H.R. 2356), S2064, S2069, S2090, S2091 [19MR], H285, H286, H295, H296, H297, H305, H306, H308, H309, H310, H311, H313, H315, H316, H317, H318, H319, H320, H323, H324, H325, H326, H327, H328, H330, H331, H332, H333, H335 [12FE], H369, H377, H393, H412, H417, H421, H425, H429, H432, H436, H441, H444, H448, H452, H455, H459, H465 [13FE]

Analyses

Bipartisan Campaign Reform Act (H.R. 2356), S1992-S1995 [18MR]

———McConnell Technical Amendments, S1529 [5MR]

Articles and editorials

AFL-CIO To Boost Mandatory Donations, Hopes To Spend $35M on November Elections, S2125 [20MR]

Armageddon, S2108 [20MR]

Bush 2000 Adviser Offered To Use Clout To Help Enron, S2107 [20MR]

Campaign Finance Lawyer Loophole, S2127 [20MR]

Campaign ``Reform'' Won't Work, S2113 [20MR]

Campaign Reform—At Last, S2109 [20MR]

Campaign-Finance Smear, S2119 [20MR]

Donations Don't Seem To Change Votes, S2341 [22MR]

*598 Soft Money, Hard Money, Strong Parties, E263-E269 [6MR]

Gaggers and Gag-Making—Hypocrisy Among the Campaign-Finance Reformers, S2119-S2121 [20MR]

House Dems Make Plans To Circumvent Campaign Reform, S2114 [20MR]

It's Not Reform, It's Deception, S2130 [20MR]

Just a Gag? Congress Prepares To Repeal Freedom of Speech, S2126 [20MR]

Just Do It, S2108 [20MR]

Marketing by Spirits Makers Gets Icy Reception, H234 [12FE]

Matter of Appearances, S2126 [20MR]

Natives Slip Through Big Loophole in Campaign Finance, S2127 [20MR]

Not Much ``Reform'' in Campaign Finance Bill, S2113 [20MR]

Now, the Unintended Consequences, S2341 [22MR]

Organized Labor Loophole, S2124 [20MR]

Plug the Flow of ``Incentives'', E1801 [9OC]

Virtue at Last! (In November), S2125 [20MR]

Why This Lobbyist Backs McCain-Feingold, S2108 [20MR]

With Victories Like These . . . Glaring Inadequacies of Shays-Meehan, S2342 [22MR]

Bills and resolutions

Dept. of Veterans Affairs: rescind memorandum in which directors of health service networks are directed to ensure that no marketing activities to enroll new veterans occur within their networks (see H.R. 5359), H6171 [10SE]

FDA: establish authority for the imposition of civil penalties for certain direct-to-consumer advertisements (see H.R. 4833), H3036 [23MY]

FEC: disapprove rule relative to prohibited and excessive political contributions (see S.J. Res. 48), S10118 [8OC] (see H.J. Res. 119), H7303 [8OC]

FTC: classify advertising or sale of a mislabeled copy-protected music disc as an unfair method of competition and an unfair and deceptive act or practice (see H.R. 5544), H7018 [3OC]

Minorities: create Federal advertising procurement opportunities for minority business concerns (see H.R. 5766), H9128 [22NO]

Pharmaceuticals: require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with promotional or marketing activities (see H.R. 5037), H4324 [27JN]

Political campaigns: ethics reform and contribution limits (H.R. 2356), consideration (see H. Res. 344), H226 [7FE]

———ethics reform and contribution limits (H.R. 2356), corrections in enrollment (see H. Con. Res. 361), H1089 [20MR]

———provide lowest advertising rate, establish airtime requirements for campaign related programming, and create political advertisement voucher system (see S. 3124), S10571 [16OC]

Privacy: prohibit use of patient databases for marketing without the express consent of the patient (see S. 3064), S10040 [7OC]

Radio: increase locally and independently produced content and facilitate competition in programming, advertising, and concert promotion (see S. 2691), S6250 [27JN]

Senate Legal Counsel: authorize testimony and representation in Senator Mitch McConnell, et. al. v. FEC, et al., and consolidation cases (see S. Res. 323), S8300 [5SE]

Taxation: limit manufacturers' deduction for advertising of FDA approved prescription drugs to the level of research and development expenditures (see S. 2486), S4064 [8MY] (see H.R. 4821), H2944 [22MY]

———treatment of direct-to-consumer advertisements of prescription drugs (see H.R. 5105), H4552 [11JY]

Tobacco products: require warning labels on tobacco products (see S. 3178), S11574 [19NO] (see H.R. 3907), H780 [7MR]

Briefs

Assessing the Impact of a Ban on Soft Money—Party Soft Money Spending in the 2000 Elections: Ray La Raja and Elizabeth Jarvis-Shean, Institute of Governmental Studies and Citizens Research Foundation, E261-E263 [6MR]

Cloture motions

Political campaigns: ethics reform and contribution limits (H.R. 2356), S2002 [18MR], S2111 [20MR]

———ethics reform and contribution limits (H.R. 2356), motion to proceed, S1840 [13MR]

Factsheets

Bipartisan Campaign Reform Act (H.R. 2356): ACLU, S2131 [20MR]

Campaign Finance Reform—Fact & Fiction: Brennan Center for Justice, S2117 [20MR]

Letters

Bipartisan Campaign Reform Act: David M. Mason and Bradley A. Smith, FEC, S2340 [22MR]

———David N. O'Steen, National Right to Life Committee and Charles H. Cunningham, NRA, S2128 [20MR]

———Laura W. Murphy, ACLU, S2131 [20MR]

———Laura W. Murphy, ACLU, and Hillary Shelton, NAACP, S2129 [20MR]

———several organizations, S2130 [20MR]

Labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors: Charles W. Fricke, and Kevin and Debra Riggins, S11675 [20NO]

NBC liquor advertising during the Winter Olympic games: George A. Hacker, Coalition for the Prevention of Alcohol Problems, H234 [12FE]

Use of soft money by a political party national committee to pay off debts or obligations: Larry Noble, Center for Responsive Politics, H371, H388 [13FE]

Memorandums

Bipartisan Campaign Reform Act: Patton Boggs LLP, H390 [13FE]

Motions

Political campaigns: ethics reform and contribution limits (H.R. 2356), H465 [13FE]

Papers

Soft Money Spending by State Parties—Where Does It Really Go? Ray La Raja and Karen Pogoda, Institute of Governmental Studies and Citizens Research Foundation, E269-E273 [6MR]

Press releases

ACLU Campaign Finance Position Protects Free Speech: ACLU, S2342 [22MR]

ACLU Double Play—New Ad Blasts Workplace Discrimination Against Gays, Shows Flaws in Campaign Finance Legislation: ACLU, S2124 [20MR]

Proposals

Technical amendments to H.R. 2356, Bipartisan Campaign Reform Act, S1529 [5MR]

Remarks in House

American Samoa: ability of U.S. nationals to contribute to political campaigns, E183 [15FE]

Bipartisan Campaign Reform Act: effective date of soft money ban, H402-H404, H452-H455 [13FE]

Entertainment industry: impact of increased obscenity, violence, drug abuse, and promiscuity on young people, H3849-H3852 [24JN]

———prohibit deceptive, targeted marketing of adult-rated media to minors (H.R. 2246), H3849 [24JN]

Freedom of speech: eliminate restrictions on the rights of citizens to communicate with elected officials or the general public, H437-H441 [13FE]

FTC: classify advertising or sale of a mislabeled copy-protected music disc as an unfair method of competition and an unfair and deceptive act or practice (H.R. 5544), E1760-E1762 [4OC]

LVMH Group (business): marketing campaign for Parfums Christian Dior, E2039 [14NO]

NBC: liquor advertising during the Winter Olympic games, H233 [12FE]

Office of National Drug Control Policy: prohibit use of national media campaign funding for payments to Ogilvy and Mather Corp., H5337-H5341 [24JY], E1490 [4SE]

Pharmaceuticals: effect of advertising on prescription drug prices, H659 [5MR]

———impact of gifts and benefits provided to physicians by prescription drug manufacturers on the efficacy and cost-effectiveness of prescription drugs, E1801 [9OC]

Political campaigns: ethics reform and contribution limits, H222 [7FE], H5223 [23JY], E1627 [19SE]

———ethics reform and contribution limits (H.R. 2356), H20 [23JA], H57-H59 [24JA], H235, H238, H240-H264, H269-H275, H279, H280 [12FE], H339-H355, H369-H466 [13FE], E175, E176, E178, E181, E183, E184 [15FE]

———ethics reform and contribution limits (H.R. 2356), consideration (H. Res. 344), H256, H266 [12FE]

———ethics reform and contribution limits (H.R. 2356), corrections in engrossment, H466 [13FE]

———ethics reform and contribution limits (H.R. 2356), corrections in enrollment (H. Con. Res. 361), H1073, H1074 [20MR]

———ethics reform and contribution limits (H.R. 2356), motion to recommit, H465 [13FE]

———ethics reform and contribution limits (H.R. 2356), unanimous-consent agreement, H266 [12FE]

———exempt communications pertaining to civil rights and issues affecting minorities from restrictions on noncandidate campaign expenditures, H426-H429 [13FE]

———exempt communications pertaining to the right to keep and bear arms from restrictions on noncandidate campaign expenditures, H421-H425 [13FE]

———exempt communications pertaining to veterans, military personnel, and senior citizens from restrictions on noncandidate campaign expenditures, H433-H436 [13FE]

———increase contribution limits to make expenditures more competitive with those of opponents using personal funds, H430-H432 [13FE]

———reduce cost of political advertising on television, H417-H421 [13FE]

———regulation of political action committees' funding of candidate advertisements, H438 [13FE]

———require disclosure of funding sources for certain candidate advocacy advertising, H426 [13FE]

Smale, John: American Advertising Federation Advertising Hall of Fame inductee, E370 [18MR]

Remarks in Senate

Dept. of Agriculture: Market Access Program funding, S652 [12FE]

Dept. of Justice: status of tobacco industry lawsuit relative to health risks and marketing and manufacturing practices, S1925 [14MR]

Dept. of Veterans Affairs: rescind memorandum in which directors of health service networks are directed to ensure that no marketing activities to enroll new veterans occur within their networks, S10664 [17OC], S10880 [13NO]

FEC: disapprove rule relative to prohibited and excessive political contributions (S.J. Res. 48), S10124-S10129 [8OC]

Government regulations: establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors, S11672-S11675 [20NO]

Pharmaceuticals: condemn industry advertising campaign relative to generic drugs, S9182 [25SE]

Political campaigns: ethics reform and contribution limits, S157 [28JA]

———ethics reform and contribution limits (H.R. 2356), S793, S796-S799, S831, S832 [14FE], S1141, S1142, S1222 [26FE], S1260 [27FE], S1991-S1997, S2002 [18MR], S2018 [19MR], S2095-S2161, S2174 [20MR], S2319 [22MR]

———ethics reform and contribution limits (H.R. 2356), corrections in enrollment (H. Con. Res. 361), S2339-S2343 [22MR]

———ethics reform and contribution limits (H.R. 2356), motion to proceed, S1840, S1841 [13MR]

———ethics reform and contribution limits (H.R. 2356), motion to proceed—unanimous-consent agreement, S1914, S1915 [14MR]

———ethics reform and contribution limits (H.R. 2356), unanimous-consent agreement, S2064 [19MR]

———ethics reform and contribution limits (H.R. 2356), unanimous-consent request, S831 [14FE], S1527-S1530 [5MR], S2037, S2038 [19MR]

———ethics reform and contribution limits (S. 27), S479 [7FE], S699 [13FE]

———increase contribution limits to make expenditures more competitive with those of opponents using personal funds, S2142 [20MR]

———prohibit State candidates from spending non-Federal money on advertisements that mention Federal candidates, S2142 [20MR]

———provide lowest advertising rate, establish airtime requirements for campaign related programming, and create political advertisement voucher system (S. 3124), S10583-S10586 [16OC]

———reduce cost of political advertising on television, S479 [7FE], S699 [13FE], S797 [14FE]

———require candidates to personally appear in television and radio advertisements that mention their opponent to qualify for advertising discounts, S2174 [20MR]

Privacy: prohibit use of patient databases for marketing without the express consent of the patient (S. 3064), S10046 [7OC]

Radio: increase locally and independently produced content and facilitate competition in programming, advertising, and concert promotion (S. 2691), S6252 [27JN]

Senate Legal Counsel: authorize testimony and representation in Senator Mitch McConnell, et. al. v. FEC, et al., and consolidation cases (S. Res. 323), S8327 [5SE]

Taxation: limit manufacturers' deduction for advertising of FDA approved prescription drugs to the level of research and development expenditures (S. 2486), S4077 [8MY], S4087 [9MY], S4824 [23MY]

Reports filed

Consideration of H.R. 2356, Bipartisan Campaign Reform Act: Committee on Rules (House) (H. Res. 344) (H. Rept. 107-358), H226 [7FE]

Statements

Impact of Fast Food: Rebecca L. Marquis, H3139 [4JN]

Ney-Wynn Is the Effective Soft Money Ban: Representative Ney, E261 [6MR]

Summaries

Buying Time 2000—Television Advertising in the 2000 Federal Elections: Brennan Center for Justice, S2118 [20MR]

Texts of

H. Con. Res. 361, corrections in enrollment of H.R. 2356, Bipartisan Campaign Reform Act, H1073 [20MR]

H. Res. 344, consideration of H.R. 2356, Bipartisan Campaign Reform Act, H256 [12FE]

H.R. 2356, Bipartisan Campaign Reform Act, H355-H364 [13FE]

S. 2486, Fair Advertising and Increased Research (FAIR) Act, S4077 [8MY]

S. 3064, Health Records Confidentiality Act, S10047 [7OC]

S. 3124, Political Campaign Broadcast Activity Improvements Act, S10583-S10585 [16OC]

S. Res. 323, Senate Legal Counsel testimony and representation in Senator Mitch McConnell, et. al. v. FEC, et al., and consolidation cases, S8312, S8327 [5SE]

S.J. Res. 48, disapprove FEC rule relative to prohibited and excessive political contributions, S10128 [8OC]

Transcripts

Bob Dole 1996 Presidential Campaign Advertisement: Republican National Committee, S2115 [20MR]